We provide the latest news
from the world of economics and finance$50,000 of ALBERTSONS COMPANIES INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to Anti-Trust, Food and Drug Regulation, Supply Chain, Farm to Market Programs, SNAP Programs and Pharmacy benefit Managers - no specific legislation.
Issues related to Anti-Trust, Food and Drug Regulation, Supply Chain, Farm to Market Programs, SNAP Programs and Pharmacy benefit Managers - no specific legislation.
Issues related to Anti-Trust, Food and Drug Regulation, Supply Chain, Farm to Market Programs, SNAP Programs and Pharmacy benefit Managers - no specific legislation."
You can find more data on corporate lobbying on Quiver Quantitative.
We have seen 259 institutional investors add shares of ACI stock to their portfolio, and 202 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Wall Street analysts have issued reports on $ACI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for ACI, check out Quiver Quantitative's $ACI forecast page.
Multiple analysts have issued price targets for $ACI recently. We have seen 3 analysts offer price targets for $ACI in the last 6 months, with a median target of $24.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.